Protein detail

NCAM1

Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)

Entry name
NCAM1
UniProt ID
EVMP score
0.50
Frequency
1
Transmembrane count
1
Protein classification
Cancer-related genesCD markersPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteinsTransporters
EVMP score: annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information
Protein Names
Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)
Protein Class
Cancer-related genesCD markersPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteinsTransporters
Protein Function
  • Predicted intracellular proteins
  • CD markers
  • Cancer-related genes:Candidate cancer biomarkers
  • Predicted secreted proteins
  • Transporters:Accessory Factors Involved in Transport
Transmembrane
719..739; Helical
Transmembrane Count
1
Entrez Gene Symbol
Gene Synonym
CD56NCAM
Gene Description
Neural cell adhesion molecule 1
Chromosome
11
Position
112961247-113278436
Frequency
1
EVMP Score
0.50
Fluorescence & Localization
NCAM1 fluorescence
Function & Pathway
Protein Function
  • Predicted intracellular proteins
  • CD markers
  • Cancer-related genes:Candidate cancer biomarkers
  • Predicted secreted proteins
  • Transporters:Accessory Factors Involved in Transport
Canonical Pathways
  • M277 Pid integrin a4b1 pathway
  • M241 Pid rac1 reg pathway
  • M156 Pid ecadherin nascent aj pathway
Mediation Categories
Clinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation
Relations & Evidence

Enzyme-Mediated Modification

3 records.

Substrate Gene SymbolEnzyme Gene SymbolEnzyme UniProt IDResidue TypeResidue OffsetModificationDatabaseReferences
NCAM1ST8SIA4Q92187N449glycosylationHPRDHPRD:17623646HPRD:9774483
NCAM1ST8SIA4Q92187N459glycosylationHPRDHPRD:17623646HPRD:9774483
NCAM1MAPK1P28482T803phosphorylationPhosphoSite

Ligand-Receptor Signaling

46 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
extracellularextracellularHPMRNoNoYesYesYes
extracellularextracellularDGIdbNoNoYesYesYes
extracellularextracellularOmniPathNoNoYesYesYes
intracellularintracellularComPPINoNoYesYesYes
intracellularintracellularGO_IntercellNoNoYesYesYes
intracellularintracellularOmniPathNoNoYesYesYes
cell_surface_ligandcell_surface_ligandconnectomeDB2020YesNoYesYesYes
cell_surface_ligandcell_surface_ligandCellChatDBYesNoYesYesYes
cell_surface_ligandcell_surface_ligandOmniPathYesNoYesYesYes
ig_likecell_adhesionHGNCYesYesYesYesYes
Page 1 of 5Next

Regulatory Interaction Network

2 records.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
GDNFP39905NCAM1P13591YesYesNoHPRDSIGNORHPRD:12837245SIGNOR:15212950
MK01P28482NCAM1P13591YesNoNoPhosphoSitePhosphoSite:28193531

Protein Complex Composition

1 record.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
NCAM1P135913PDBPDB:5aeaPDB:2vkxPDB:2e3vPDB:2vkwPDB:3mtr

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Size Exclusion ChromatographyMass spectrometry128211531
Sequence, Structure & Domains

Sequences

Length
858
Mass
94,574
Sequence
MLQTKDLIWTLFFLGTAVSLQVDIVPSQGEISVGESKFFLCQVAGDAKDKDISWFSPNGEKLTPNQQRISVVWNDDSSSTLTIYNANIDDAGIYKCVVTGEDGSESEATVNVKIFQKLMFKNAPTPQEFREGEDAVIVCDVVSSLPPTIIWKHKGRDVILKKDVRFIVLSNNYLQIRGIKKTDEGTYRCEGRILARGEINFKDIQVIVNVPPTIQARQNIVNATANLGQSVTLVCDAEGFPEPTMSWTKDGEQIEQEEDDEKYIFSDDSSQLTIKKVDKNDEAEYICIAENKAGEQDATIHLKVFAKPKITYVENQTAMELEEQVTLTCEASGDPIPSITWRTSTRNISSEEKASWTRPEKQETLDGHMVVRSHARVSSLTLKSIQYTDAGEYICTASNTIGQDSQSMYLEVQYAPKLQGPVAVYTWEGNQVNITCEVFAYPSATISWFRDGQLLPSSNYSNIKIYNTPSASYLEVTPDSENDFGNYNCTAVNRIGQESLEFILVQADTPSSPSIDQVEPYSSTAQVQFDEPEATGGVPILKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKTQPVQGEPSAPKLEGQMGEDGNSIKVNLIKQDDGGSPIRHYLVRYRALSSEWKPEIRLPSGSDHVMLKSLDWNAEYEVYVVAENQQGKSKAAHFVFRTSAQPTAIPANGSPTSGLSTGAIVGILIVIFVLLLVVVDITCYFLNKCGLFMCIAVNLCGKAGPGAKGKDMEEGKAAFSKDESKEPIVEVRTEEERTPNHDGGKHTEPNETTPLTEPEKGPVEAKPECQETETKPAPAEVKTVPNDATQTKENESKA
Alternative Products
Event=Alternative splicing; Named isoforms=6; Name=1; IsoId=P13591-2; Sequence=Displayed; Name=2; Synonyms=N-CAM 140; IsoId=P13591-1; Sequence=VSP_034818; Name=3; Synonyms=N-CAM 120; IsoId=P13591-3, P13592-2; Sequence=VSP_034818, VSP_034822, VSP_034824, VSP_034825; Name=4; IsoId=P13591-4; Sequence=VSP_034818, VSP_034824, VSP_034825; Name=5; Synonyms=C; IsoId=P13591-5, P13592-1; Sequence=VSP_034821, VSP_034823; Name=6; IsoId=P13591-6; Sequence=VSP_034819, VSP_034820
Alternative Sequence
354..363; Missing (in isoform 2, isoform 3 and isoform 4); 364; T -> V (in isoform 6); 365..858; Missing (in isoform 6); 609..665; QGEPSAPKLEGQMGEDGNSIKVNLIKQDDGGSPIRHYLVRYRALSSEWKPEIRLPSG -> HSPPPPASASSSTPVPLSPPDTTWPLPALATTEPAKNIAQNHCCNMFQAGLHNALMK (in isoform 5); 609; Q -> HSPPPPASASSSTPVPLSPPDTTWPLPALATTEPAK (in isoform 3); 666..858; Missing (in isoform 5); 712..736; NGSPTSGLSTGAIVGILIVIFVLLL -> TLGGNSASYTFVSLLFSAVTLLLLC (in isoform 3 and isoform 4); 737..858; Missing (in isoform 3 and isoform 4)

3D Structural Models

Helix
88..90; 481..483; 562..568
Beta Strand
21..32; 37..45; 51..55; 69..75; 78..83; 92..99; 105..115; 414..419; 422..426; 432..442; 445..450; 453..456; 458..460; 462..468; 471..476; 485..492; 497..506; 514..520; 525..530; 542..549; 556..561; 569..573; 581..590; 601..604; 616..621; 628..633; 638..640; 644..651; 660..662; 668..671; 676..678; 679..688; 696..701
3D Structure
NMR spectroscopy (1); X-ray crystallography (6)

Domain & Motif Annotations

Compositional Bias
768..809; Basic and acidic residues; 817..834; Basic and acidic residues
Domain (FT)
20..111; Ig-like C2-type 1; 116..205; Ig-like C2-type 2; 212..301; Ig-like C2-type 3; 308..413; Ig-like C2-type 4; 416..501; Ig-like C2-type 5; 509..608; Fibronectin type-III 1; 611..706; Fibronectin type-III 2
Region
766..858; Disordered
Clinical Relevance
Disease Involvement
Cancer-related genes
Biomarker
Phase 1/2; Phase 1
Drug Targets
Clinical trial target